Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02NRI
|
||||
| Former ID |
DNC014340
|
||||
| Drug Name |
Eryvarin D
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C21H20O4
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=CC2=C1OC3=C2COC4=C3C=CC(=C4)O)OC)C
|
||||
| InChI |
1S/C21H20O4/c1-12(2)4-6-15-18(23-3)9-8-14-17-11-24-19-10-13(22)5-7-16(19)21(17)25-20(14)15/h4-5,7-10,22H,6,11H2,1-3H3
|
||||
| InChIKey |
BYZVMAQRPFEPSV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||